BREACHES OF CODE OF PHARMACEUTICAL MARKETING PRACTICE

被引：0

|

作者：

不详

机构：

来源：

LANCET | 1988年 / 1卷 / 8595期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1179 / 1179

页数：1

相关论文

共 50 条

[1] Bayer breaches code of practice
Loeb, Josh
[J]. VETERINARY RECORD, 2020, 186 (10) : 304 - 304
[2] Zoetis breaches NOAH code of practice
不详
[J]. VETERINARY RECORD, 2021, 189 (02) : 60 - 60
[3] CODE OF MARKETING PRACTICE
TATTLE, PT
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1978, 118 (04) : 352 - &
[4] CODE OF MARKETING PRACTICE
不详
[J]. LANCET, 1980, 1 (8180): : 1239 - 1240
[5] CODE OF MARKETING PRACTICE
MARTIN, RW
[J]. NEW ZEALAND MEDICAL JOURNAL, 1974, 80 (530) : 568 - 568
[6] Implications of "market baskets," a pharmaceutical marketing practice
Rhame, FS
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (12): : 1134 - 1134
[7] Separating practice guidelines from pharmaceutical marketing
Eichacker, Peter Q.
Natanson, Charles
Danner, Robert L.
[J]. CRITICAL CARE MEDICINE, 2007, 35 (12) : 2877 - 2878
[8] Separating practice guidelines from pharmaceutical marketing - Reply
Dellinger, R. P. Hillip
Durbin, Charles G., Jr.
[J]. CRITICAL CARE MEDICINE, 2007, 35 (12) : 2878 - 2880
[9] Medicines Australia Code of Conduct: breaches
不详
[J]. AUSTRALIAN PRESCRIBER, 2009, 32 (06) : 160 - 161
[10] Medicines Australia Code of Conduct: breaches
不详
[J]. AUSTRALIAN PRESCRIBER, 2006, 29 (06) : 164 - 164

← 1 2 3 4 5 →